-: So my name is Renee Donahue.
I'm a staff scientist at the National Cancer Institute
at the National Institutes of Health in Bethesda, Maryland.
I work in the Laboratory of Tumor Immunology and Biology
which is a translational research program
composed of seven preclinical groups
and we work very closely with a clinical trials group.
I lead one of those seven groups,
and my team especially works very close
with the clinical trials team.
We're looking to basically examine
the immune responses of patients
that are enrolled in our clinical trials at the NCI,
and we're looking basically for correlates
or things that associate with clinical responses of patients
or things that associate with the development
of adverse events in these patients.